GGrantIndex
Sort

64,565 grants matching drug discovery

A Preclinical Program for Targeting Mycobacterium tuberculosis KasA

$795,178
Joel Stephen Freundlich · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI

Inhibitors of TrkB Signaling

$795,160
James O. McNamara · Duke University · UH3 · FY2020 · NS

Core 3: Drug Discovery and Development Core

$795,092
Mark J Suto · University Of Alabama At Birmingham · U54 · FY2019 · ES

Discovery of GPR52 ligand probes for cocaine use disorder

$795,090
John A Allen · University Of Texas Med Br Galveston · R01 · FY2025 · DA

A Breath-based Medicaton Adherence Monitoring System for HIVAIDS Therapies

$795,072
Richard J Melker · Xhale, Inc. · R44 · FY2010 · MH

A Novel Approach to Restore Epithelial Barrier Homeostasis to Treat Inflammatory Bowel Disease

$795,004
W Vallen Graham · Thelium Therapeutics Inc · R44 · FY2022 · DK

Sustained delivery technology for Cyclosporine A in the treatment of autoimmune response

$795,000
Roman Domszy · Lynthera Corporation · R44 · FY2023 · EY

Sustained delivery technology for Cyclosporine A in the treatment of autoimmune response

$795,000
Roman Domszy · Lynthera Corporation · R44 · FY2024 · EY

Evolved cefiderocol resistance and cross protection

$794,849
Peter Allan Jorth · Cedars-Sinai Medical Center · R01 · FY2025 · AI

Bay Area Cancer Target Discovery and Development Network

$794,824
Michael T McManus · University Of California, San Francisco · U01 · FY2012 · CA

Pathophysiological mechanisms of cannabidiol in stress regulation

$794,696
Keren Bachi · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH

Evaluating the Impact of Non-COPD Medications on COPD Management

$794,681
Katsiaryna Bykov · Brigham And Women'S Hospital · R01 · FY2024 · HL

The Unviersity of Michigan Injury Center

$794,662
Rebecca M. Cunningham · University Of Michigan At Ann Arbor · R49 · FY2013 · CE

The Unviersity of Michigan Injury Center

$794,662
Rebecca M. Cunningham · University Of Michigan At Ann Arbor · R49 · FY2015 · CE

The Unviersity of Michigan Injury Center

$794,662
Rebecca M. Cunningham · University Of Michigan At Ann Arbor · R49 · FY2014 · CE

Columbia Injury Control Research Center

$794,662
Guohua Li · Columbia University Health Sciences · R49 · FY2014 · CE

Columbia Injury Control Research Center

$794,662
Guohua Li · Columbia University Health Sciences · R49 · FY2013 · CE

Columbia Injury Control Research Center

$794,662
Guohua Li · Columbia University Health Sciences · R49 · FY2015 · CE

Multiplexing methods to reduce sequencing costs

$794,628
Atray Dixit · Coral Genomics, Inc. · R44 · FY2020 · HG

Targeting the Urgent Need for New Antibiotics against Gram-negative ‘Superbugs’

$794,600
Jian Li · Monash University · R01 · FY2019 · AI

Discovery of Addiction-Related Genes with Advanced Mouse Resources

$794,526
Elissa J Chesler · Jackson Laboratory · R01 · FY2024 · DA

Development of Drugs Acting at Adenosine Receptors

$794,513
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

Target based discovery of next generation pyrazinamide

$794,409
Veronique Dartois · Hackensack University Medical Center · R01 · FY2021 · AI

Data Coordination Center for PDX Net

$794,406
Jeffrey Hsu-Min Chuang · Jackson Laboratory · U24 · FY2022 · CA

Epoch Telemetry System for Long-Term Monitoring of Biopotentials

$794,403
Mark J. Lehmkuhle · Epitel, Inc. · R44 · FY2014 · NS